Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Cost-effectiveness analysis of grass pollen specific immunotherapy in children with allergic rhinitis compared to the standard of care symptomatic treatment in Portugal
Publication

Publications

Cost-effectiveness analysis of grass pollen specific immunotherapy in children with allergic rhinitis compared to the standard of care symptomatic treatment in Portugal

Title
Cost-effectiveness analysis of grass pollen specific immunotherapy in children with allergic rhinitis compared to the standard of care symptomatic treatment in Portugal
Type
Article in International Scientific Journal
Year
2023
Authors
Farraia, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Paciência, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Mendes, FC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rufo, JC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Delgado, L
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Moreira, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 55
Pages: 212-228
ISSN: 1764-1489
Other information
Authenticus ID: P-00X-3W6
Resumo (PT):
Abstract (EN): Background. Cost-effectiveness studies evaluating allergen immunothera-py (AIT) in children are scarce. We aim to compare the cost-effectiveness of subcutaneous (SCIT) and sublingual immunotherapy (SLIT) against stan-dard-of-care (SOC) treatment in children with grass pollen allergic rhinitis. Methods. We created a Markov model to compare the three strategies over a 10-year horizon. SOC was the reference to calculate the incremental cost-ef-fectiveness ratio (ICER). Deterministic and probabilistic sensitivity analysis were used to assess models' uncertainty. Results. We obtained an ICER of 12,605euro and 6,318euro for SLIT and SCIT, respectively. In sensitivity analysis, SCIT was more cost-effective than SLIT. Conclusions. AIT is cost-effective in children with grass pollen allergic rhinitis, especially for the subcutaneous route.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 17
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The show must go on. The impacts of SARS-CoV-2 pandemic on cutaneous allergology and patch testing (2020)
Another Publication in an International Scientific Journal
Alpalhao, M; Pedro Pimentel-Nunes
The athlete "out of breath" (2016)
Another Publication in an International Scientific Journal
Couto, M; Moreira, André
Translation to Portuguese and cultural adaptation of Food Allergy Quality of Life Questionnaire - Parent Form (FAQLQ-PF) (2016)
Article in International Scientific Journal
Couto, M; Silva, D; Piedade, S; Borrego, LM; Flokstra de Blok, B; Galvin, AD; Morais Almeida, M
The Vespid Allergy Quality of Life Questionnaire - cultural adaptation and translation to Portuguese (2017)
Article in International Scientific Journal
Silva, D; Pereira, AM; Santos, N; Amaral, L; Delgado, L; Elberink, JNGO; Coimbra, A

See all (20)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-09-01 at 17:35:17 | Privacy Policy | Personal Data Protection Policy | Whistleblowing